LGN · Legence Corp.

The thesis

Legence's order book and raised 2026 guidance still support the business, but the shares have lost another leg of value without a new operating release, and the third-quarter report, expected around 12 November 2026, decides whether revenue keeps pace. The adjusted close on 27 October 2026 was $38.06, 62.8% below the 52-week high of $102.27 and 36.4% lower than three months earlier. The 14-day relative strength index (a 0–100 momentum gauge) was 15.3, a deeply oversold reading.

The previous note put the close at $44.91 on 14 October 2026, under the $45 December 2025 sponsor offering price. The shares have since closed under the $40 invalidation level named in that note. Analyst targets were cut again: RBC Capital lowered its target to $90 on 15 October 2026 and kept Outperform, and Barclays lowered its target to $60 on 19 October 2026 and kept Equal-Weight (Benzinga). Company news shows no operating release since the 13 August 2026 second-quarter results.

The narrative is maturing and sentiment is turning: the guidance raise dates to 13 August 2026, and the only fresh items since are three analyst target cuts between 8 October 2026 and 19 October 2026. The November report is the next operating datapoint.

Bullish and bearish views on Legence Corp.

The bull case on Legence Corp. (LGN), in brief: Growth extends beyond acquisitions. The bear case: The shares sit under both offering prices.

Bull case

• Growth extends beyond acquisitions. The 13 August 2026 second-quarter release reported revenue of $1.26 billion, up 110.7% year over year. Growth excluding The Bowers Group acquisition was about 60%.
• On 13 August 2026 management raised full-year revenue guidance to $4.7–4.8 billion and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) guidance to $565–585 million.
• Third-quarter guidance sets a clear test. The 13 August 2026 release guided third-quarter revenue to $1.225–1.275 billion and adjusted EBITDA to $150–160 million. A result inside or above those ranges would show the order book converting to sales.
• Targets still sit above the price. Barclays' $60 target (19 October 2026), Stifel's $82 (8 October 2026) and RBC's $90 (15 October 2026) all exceed the $38.06 close. StockAnalysis showed 17 analysts averaging $102.53 as of 30 September 2026.
• Financing costs fell. The $995 million term loan was amended on 28 May 2026 to SOFR (Secured Overnight Financing Rate) plus 2.00%, lowering interest expense against a thin net income line.

Bear case

• The shares sit under both offering prices. The 27 October 2026 close of $38.06 is below the $45 December 2025 and $54.00 April 2026 sponsor offering prices. The slide followed a results release that raised guidance.
• Sponsor supply is a recurring overhang. Blackstone-affiliated holders sold 8,402,178 shares at $45 in December 2025 and 15,394,112 shares at $54.00 in April 2026, about $831 million gross (Form 10-Q for the quarter ended 30 June 2026). The company has been controlled since its September 2025 IPO.
• Analysts keep trimming. RBC lowered its target to $90 on 15 October 2026, Barclays to $60 on 19 October 2026, and Stifel to $82 on 8 October 2026 (Benzinga). BTIG lowered its target to $100 from $120 in September, per search summaries of the analyst record.
• Adjusted and reported profit diverge. Second-quarter adjusted EBITDA was $154.6 million against a $27.8 million net loss attributable to Legence, which included about $41.1 million of impairments (13 August 2026 release).
• Margins narrowed. MarketBeat reported on 14 August 2026 that second-quarter gross margin fell to 17.4% from 21.5% a year earlier.

Price setup

The adjusted close on 27 October 2026 was $38.06. The 52-week high is $102.27, and the shares fell from $44.91 on 14 October 2026 to $38.06 in under two weeks. The $40 level in the previous note has been breached on a closing basis, so the earlier invalidation condition has fired and the frame is reset lower.

Overhead, the $45 and $54.00 sponsor offering prices are the nearest reference levels where the last two secondary sales priced. The 14-day relative strength index of 15.3 shows selling concentrated into a short window.

The invalidation level for this note is a daily close below $34. Crowding evidence is mixed: the shares are far below their high, but sponsor selling history, an earnings report about two weeks away and a run of target cuts all sit in the same window.

Catalysts, next 30 days

• ~12 November 2026, est.: third-quarter 2026 results. The date is not yet announced. The report tests the $1.225–1.275 billion revenue guidance, the $150–160 million adjusted EBITDA guidance and the $4.7–4.8 billion full-year outlook.
• After the report: sponsor trading window. Earlier secondary sales followed open windows, so a new offering announcement is possible once results are out.

Elapsed catalysts

• ~30 October 2026 to ~3 November 2026, est.: earnings-date notice. The company announced its Q3 2025 date on 31 October 2025 and its Q2 2026 date on 27 July 2026, so a notice is likely in this window. (passed 3d ago)

What would change the view

The case breaks if third-quarter revenue comes in under $1.225 billion, if management cuts the $4.7–4.8 billion full-year revenue guidance, or if backlog falls below the $5.67 billion reported at 30 June 2026. A new secondary offering by Blackstone-affiliated holders priced below the $38.06 close would add to the supply problem.

On price, a daily close below $34 ends the thesis as written.

The case improves if revenue lands inside guidance, backlog grows past $5.67 billion, and the shares recover the $45 sponsor offering price.

What it trades with

Legence sells heating, cooling and building-systems engineering and installation, and its growth is tied to commercial and data-center construction spending. The company does not break out data-center exposure in the figures cited here. Interest cost on the $995 million term loan moves with short-term rates, and Blackstone-affiliated holders control the share supply, so sponsor selling moves the shares independently of operating news.